No previous study has been conducted in Nigeria on the role of neutrophil elastase in predicting preterm birth. The present study aimed to determine the role of the neutrophil elastase test in ...
New research shows that Rytvela, an anti-inflammatory drug candidate, decreased premature birth and infant mortality when ...
No previous study has been conducted in Nigeria on the role of neutrophil elastase in predicting preterm birth. The present study aimed to determine the role of the neutrophil elastase test in ...
In 2017, Dr. Barbi Phelps-Sandall, an obstetrician who has been practicing in the San Francisco Bay area for more than two decades, had just learned about a new blood test only available at select ...
LAS VEGAS (FOX5) — A blood test that identifies women at risk for preterm birth has shown promising results in a major study, with researchers reporting a 22% reduction in neonatal intensive care unit ...
Please provide your email address to receive an email when new articles are posted on . There is no neonatal benefit or harm when using tocolytic drugs for threatened premature birth after 30 weeks’ ...
Scientists have developed an inexpensive blood test to predict a pregnant woman’s due date and possibly identify women who are at risk of giving birth prematurely. Scientists have developed an ...
In 2024, Sera completed the PRIME trial. Substantial reductions were observed in neonatal morbidity, length of stay, NICU admissions and NICU length of stay. Data analysis suggested that 41 screenings ...
The new compound called Rytvela prevents preterm birth and organ damage in animal studies by stopping inflammation, whereas the common drug nifedipine failed.
Preterm birth - defined as delivery before the 37 th week of pregnancy - is one of the leading causes of infant deaths in the United States. Babies born prematurely are also at an increased risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results